Fonar Corporation reports 4% revenue increase and 33% net income decrease for Q1 fiscal 2026
Fonar Corporation reported total revenues - net of $26.0 million for the quarter ended September 30, 2025, a 4% increase compared to the same period last year. Income from operations decreased 30% to $3.2 million, while consolidated net income fell 33% to $2.7 million. Diluted net income per common share was $0.34, down 26%. Cash and cash equivalents stood at $54.3 million, a 4% decrease since June 30, 2025. Revenues from the Fonar segment, including product sales, upgrades, service, and repair fees, rose 14% to $2.5 million. Total costs and expenses increased 12% to $22.8 million. The company's diagnostic imaging management subsidiary, Health Management Company of America, managed 44 MRI scanners and reported a scan volume of 55,106 for the quarter, 3.9% higher than the same quarter last year. The net book value per common share was $26.02. The ratio of total assets to total liabilities was 3.8. Net cash flow provided by operating activities was $1.7 million.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fonar Corporation published the original content used to generate this news brief via Newsfile (Ref. ID: 273645) on November 10, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.